These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32785927)

  • 1. Ushering in the Era of Precision Medicine.
    Oncology (Williston Park); 2020 Aug; 34(8):314-316. PubMed ID: 32785927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Society of Gastrointestinal Oncology Conference Abstracts.
    Oncology (Williston Park); 2020 Nov; 34(11):468-476. PubMed ID: 33206986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
    Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
    [No Abstract]   [Full Text] [Related]  

  • 4. Next-Generation Sequencing Testing in GI Cancer: A Patient's "Right"? Or Wrong?
    Hochster HS
    Oncology (Williston Park); 2020 Aug; 34(8):295. PubMed ID: 32785921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Medicine in Gastrointestinal Pathology.
    Wang DH; Park JY
    Arch Pathol Lab Med; 2016 May; 140(5):449-60. PubMed ID: 27128302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets in GI malignancies - A pathologist's perspective.
    Pawar S; Sharma A
    Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S43-S51. PubMed ID: 34135137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCRUM-Japan GI-SCREEN and MONSTAR-SCREEN: Path to the realization of biomarker-guided precision oncology in advanced solid tumors.
    Nakamura Y; Fujisawa T; Taniguchi H; Bando H; Okamoto W; Tsuchihara K; Yoshino T; Ohtsu A
    Cancer Sci; 2021 Nov; 112(11):4425-4432. PubMed ID: 34510657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current state of molecular profiling in gastrointestinal malignancies.
    Mukherji R; Yin C; Hameed R; Alqahtani AZ; Kulasekaran M; He AR; Weinberg BA; Marshall JL; Hartley ML; Noel MS
    Biol Direct; 2022 Jun; 17(1):15. PubMed ID: 35668531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiles in foregut oncology.
    Sukharamwala P; Hennessey D; Wood T; Singh S; Ryan C; Rosemurgy A
    Cancer Genet; 2016 Dec; 209(12):537-553. PubMed ID: 27887938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Gastrointest Endosc; 2016 Dec; 84(6):950-958.e3. PubMed ID: 27118626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of personalized medicine in GI cancers.
    Chao C
    J Gastrointest Surg; 2012 Sep; 16(9):1641-4. PubMed ID: 22744640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
    Keller RB; Mazor T; Sholl L; Aguirre AJ; Singh H; Sethi N; Bass A; Nagaraja AK; Brais LK; Hill E; Hennessey C; Cusick M; Del Vecchio Fitz C; Zwiesler Z; Siegel E; Ovalle A; Trukhanov P; Hansel J; Shapiro GI; Abrams TA; Biller LH; Chan JA; Cleary JM; Corsello SM; Enzinger AC; Enzinger PC; Mayer RJ; McCleary NJ; Meyerhardt JA; Ng K; Patel AK; Perez KJ; Rahma OE; Rubinson DA; Wisch JS; Yurgelun MB; Hassett MJ; MacConaill L; Schrag D; Cerami E; Wolpin BM; Nowak JA; Giannakis M
    JCO Precis Oncol; 2023 Jan; 7():e2200342. PubMed ID: 36634297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of next-generation sequencing in gastrointestinal and liver tumors.
    Mikhail S; Faltas B; Salem ME; Bekaii-Saab T
    Cancer Lett; 2016 May; 374(2):187-91. PubMed ID: 26916979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
    Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
    Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.
    Nakamura Y; Taniguchi H; Ikeda M; Bando H; Kato K; Morizane C; Esaki T; Komatsu Y; Kawamoto Y; Takahashi N; Ueno M; Kagawa Y; Nishina T; Kato T; Yamamoto Y; Furuse J; Denda T; Kawakami H; Oki E; Nakajima T; Nishida N; Yamaguchi K; Yasui H; Goto M; Matsuhashi N; Ohtsubo K; Yamazaki K; Tsuji A; Okamoto W; Tsuchihara K; Yamanaka T; Miki I; Sakamoto Y; Ichiki H; Hata M; Yamashita R; Ohtsu A; Odegaard JI; Yoshino T
    Nat Med; 2020 Dec; 26(12):1859-1864. PubMed ID: 33020649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future therapies for targeting HER2 mutations in gastrointestinal cancer.
    El Dika I; Ilson DH
    Expert Rev Anticancer Ther; 2018 Nov; 18(11):1085-1092. PubMed ID: 30092682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ushering in the next generation of precision trials for pediatric cancer.
    DuBois SG; Corson LB; Stegmaier K; Janeway KA
    Science; 2019 Mar; 363(6432):1175-1181. PubMed ID: 30872517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona.
    Baraniskin A; Van Laethem JL; Wyrwicz L; Guller U; Wasan HS; Matysiak-Budnik T; Gruenberger T; Ducreux M; Carneiro F; Van Cutsem E; Seufferlein T; Schmiegel W
    Eur J Cancer; 2017 Nov; 86():305-317. PubMed ID: 29065378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for personalized medicine in GI cancers.
    Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The possibility of clinical sequencing in the management of cancer.
    Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
    Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.